Vi Lam[Author] - Search Results

Year	Number of Results
2018	1
2019	1
2020	1
2021	5
2022	4
2023	3
2024	0

1

Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.

Wang X, Chen C, Vuong D, Rodriguez-Rodriguez S, Lam V, Roleder C, Wang JH, Kambhampati S, Berger A, Pennock N, Torka P, Hernandez-Ilizaliturri F, Siddiqi T, Wang L, Xia Z, Danilov AV. Wang X, et al. Among authors: lam v. Leukemia. 2023 Jun;37(6):1324-1335. doi: 10.1038/s41375-023-01889-x. Epub 2023 Apr 8. Leukemia. 2023. PMID: 37031300 Free PMC article.

2

T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.

Lam V, Roleder C, Liu T, Bruss N, Best S, Wang X, Phillips T, Shouse G, Berger AJ, Alinari L, Wang L, Siddiqi T, Pennock ND, Danilov AV. Lam V, et al. Mol Cancer Ther. 2023 Sep 5;22(9):1040-1051. doi: 10.1158/1535-7163.MCT-22-0762. Mol Cancer Ther. 2023. PMID: 37420267 Free PMC article.

3

Pre-Clinical Activity of Amino-Alcohol Dimeric Naphthoquinones as Potential Therapeutics for Acute Myeloid Leukemia.

Ferraris D, Lapidus R, Truong P, Bollino D, Carter-Cooper B, Lee M, Chang E, LaRossa-Garcia M, Dash S, Gartenhaus R, Choi EY, Kipe O, Lam V, Mason K, Palmer R, Williams E, Ambulos N, Kamangar F, Zhang Y, Kapadia B, Jing Y, Emadi A. Ferraris D, et al. Among authors: lam v. Anticancer Agents Med Chem. 2022;22(2):239-253. doi: 10.2174/1871520621666210602131558. Anticancer Agents Med Chem. 2022. PMID: 34080968

4

Proapoptotic and immunomodulatory effects of SYK inhibitor entospletinib in combination with obinutuzumab in patients with chronic lymphocytic leukaemia.

Lam V, Best S, Kittai A, Orand K, Spurgeon SE, Liu T, Danilov AV. Lam V, et al. Br J Clin Pharmacol. 2022 Feb;88(2):836-841. doi: 10.1111/bcp.14962. Epub 2021 Jul 19. Br J Clin Pharmacol. 2022. PMID: 34196037 Free article. Clinical Trial.

5

Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies.

Kittai AS, Best S, Thurlow B, Lam V, Hashiguchi T, Goodyear S, Persky DO, Okada C, Park B, Spurgeon SE, Danilov AV. Kittai AS, et al. Among authors: lam v. Haematologica. 2021 Jul 1;106(7):2022-2025. doi: 10.3324/haematol.2020.270298. Haematologica. 2021. PMID: 33504141 Free PMC article. No abstract available.

6

The influence of twist angle on the electronic and phononic band of 2D twisted bilayer SiC.

Nguyen HV, Nguyen PM, Lam VT, Osamu S, Tran HTT. Nguyen HV, et al. RSC Adv. 2023 Nov 6;13(46):32641-32647. doi: 10.1039/d3ra04525k. eCollection 2023 Oct 31. RSC Adv. 2023. PMID: 37936646 Free PMC article.

7

Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.

Best S, Lam V, Liu T, Bruss N, Kittai A, Danilova OV, Murray S, Berger A, Pennock ND, Lind EF, Danilov AV. Best S, et al. Among authors: lam v. Leukemia. 2021 Jan;35(1):156-168. doi: 10.1038/s41375-020-0794-0. Epub 2020 Mar 16. Leukemia. 2021. PMID: 32203139 Free PMC article.

8

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma.

Thieme E, Liu T, Bruss N, Roleder C, Lam V, Wang X, Nechiporuk T, Shouse G, Danilova OV, Bottomly D, McWeeney SK, Tyner JW, Kurtz SE, Danilov AV. Thieme E, et al. Among authors: lam v. Cell Death Dis. 2022 Mar 16;13(3):246. doi: 10.1038/s41419-022-04684-1. Cell Death Dis. 2022. PMID: 35296646 Free PMC article.

9

NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells.

Kittai AS, Danilova OV, Lam V, Liu T, Bruss N, Best S, Fan G, Danilov AV. Kittai AS, et al. Among authors: lam v. Oncotarget. 2021 Sep 28;12(20):2068-2074. doi: 10.18632/oncotarget.28063. eCollection 2021 Sep 28. Oncotarget. 2021. PMID: 34611480 Free PMC article.

10

Ab Initio Investigation of the Hydrogen Interaction on Two Dimensional Silicon Carbide.

Nguyen PM, Van Nguyen H, Lam VT, Nhu Duong TT, Chong TV, Tran HTT. Nguyen PM, et al. ACS Omega. 2022 Dec 13;7(51):47642-47649. doi: 10.1021/acsomega.2c04532. eCollection 2022 Dec 27. ACS Omega. 2022. PMID: 36591197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year